A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult Participants (Q113945711)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult Participants |
clinical trial |
Statements
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of a Single Dose of ALXN1210 Administered Subcutaneously Compared to Intravenously in Healthy Subjects (English)
0 references
19 August 2016
0 references
18 July 2017
0 references
42
0 references
25 year
0 references
55 year
0 references